252 related articles for article (PubMed ID: 32901874)
1. Anti‑proliferative effect of honokiol on SW620 cells through upregulating BMP7 expression via the TGF‑β1/p53 signaling pathway.
Li Q; Ma Y; Liu XL; Mu L; He BC; Wu K; Sun WJ
Oncol Rep; 2020 Nov; 44(5):2093-2107. PubMed ID: 32901874
[TBL] [Abstract][Full Text] [Related]
2. BMP7 mediates the anticancer effect of honokiol by upregulating p53 in HCT116 cells.
Liu RX; Ren WY; Ma Y; Liao YP; Wang H; Zhu JH; Jiang HT; Wu K; He BC; Sun WJ
Int J Oncol; 2017 Sep; 51(3):907-917. PubMed ID: 28731124
[TBL] [Abstract][Full Text] [Related]
3. Anticancer effects of oridonin on colon cancer are mediated via BMP7/p38 MAPK/p53 signaling.
Liu RX; Ma Y; Hu XL; Ren WY; Liao YP; Wang H; Zhu JH; Wu K; He BC; Sun WJ
Int J Oncol; 2018 Nov; 53(5):2091-2101. PubMed ID: 30132514
[TBL] [Abstract][Full Text] [Related]
4. Oridonin inhibits the proliferation of human colon cancer cells by upregulating BMP7 to activate p38 MAPK.
Ren CM; Li Y; Chen QZ; Zeng YH; Shao Y; Wu QX; Yuan SX; Yang JQ; Yu Y; Wu K; He BC; Sun WJ
Oncol Rep; 2016 May; 35(5):2691-8. PubMed ID: 26986967
[TBL] [Abstract][Full Text] [Related]
5. Honokiol suppresses proliferation and induces apoptosis via regulation of the miR‑21/PTEN/PI3K/AKT signaling pathway in human osteosarcoma cells.
Yang J; Zou Y; Jiang D
Int J Mol Med; 2018 Apr; 41(4):1845-1854. PubMed ID: 29393336
[TBL] [Abstract][Full Text] [Related]
6. Honokiol Affects Stem Cell Viability by Suppressing Oncogenic YAP1 Function to Inhibit Colon Tumorigenesis.
Subramaniam D; Ponnurangam S; Ramalingam S; Kwatra D; Dandawate P; Weir SJ; Umar S; Jensen RA; Anant S
Cells; 2021 Jun; 10(7):. PubMed ID: 34206989
[TBL] [Abstract][Full Text] [Related]
7. Honokiol Decreases Lung Cancer Metastasis through Inhibition of the STAT3 Signaling Pathway.
Pan J; Lee Y; Zhang Q; Xiong D; Wan TC; Wang Y; You M
Cancer Prev Res (Phila); 2017 Feb; 10(2):133-141. PubMed ID: 27849557
[TBL] [Abstract][Full Text] [Related]
8. Honokiol affects melanoma cell growth by targeting the AMP-activated protein kinase signaling pathway.
Kaushik G; Kwatra D; Subramaniam D; Jensen RA; Anant S; Mammen JM
Am J Surg; 2014 Dec; 208(6):995-1002; discussion 1001-2. PubMed ID: 25450590
[TBL] [Abstract][Full Text] [Related]
9. Honokiol in combination with radiation targets notch signaling to inhibit colon cancer stem cells.
Ponnurangam S; Mammen JM; Ramalingam S; He Z; Zhang Y; Umar S; Subramaniam D; Anant S
Mol Cancer Ther; 2012 Apr; 11(4):963-72. PubMed ID: 22319203
[TBL] [Abstract][Full Text] [Related]
10. Honokiol inhibits androgen receptor activity in prostate cancer cells.
Hahm ER; Karlsson AI; Bonner MY; Arbiser JL; Singh SV
Prostate; 2014 Apr; 74(4):408-20. PubMed ID: 24338950
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol inactivates PI3K/Akt signaling through upregulating BMP7 in human colon cancer cells.
Zeng YH; Zhou LY; Chen QZ; Li Y; Shao Y; Ren WY; Liao YP; Wang H; Zhu JH; Huang M; He F; Wang J; Wu K; He BC
Oncol Rep; 2017 Jul; 38(1):456-464. PubMed ID: 28534975
[TBL] [Abstract][Full Text] [Related]
12. Honokiol induces autophagy and apoptosis of osteosarcoma through PI3K/Akt/mTOR signaling pathway.
Li Z; Dong H; Li M; Wu Y; Liu Y; Zhao Y; Chen X; Ma M
Mol Med Rep; 2018 Feb; 17(2):2719-2723. PubMed ID: 29207060
[TBL] [Abstract][Full Text] [Related]
13. Honokiol suppresses pancreatic tumor growth, metastasis and desmoplasia by interfering with tumor-stromal cross-talk.
Averett C; Bhardwaj A; Arora S; Srivastava SK; Khan MA; Ahmad A; Singh S; Carter JE; Khushman M; Singh AP
Carcinogenesis; 2016 Nov; 37(11):1052-1061. PubMed ID: 27609457
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of BMP‑7 reverses TGF‑β1‑induced epithelial‑mesenchymal transition by attenuating the Wnt3/β‑catenin and TGF-β1/Smad2/3 signaling pathways in HK‑2 cells.
Song Y; Lv S; Wang F; Liu X; Cheng J; Liu S; Wang X; Chen W; Guan G; Liu G; Peng C
Mol Med Rep; 2020 Feb; 21(2):833-841. PubMed ID: 31974602
[TBL] [Abstract][Full Text] [Related]
15. Honokiol activates LKB1-miR-34a axis and antagonizes the oncogenic actions of leptin in breast cancer.
Avtanski DB; Nagalingam A; Bonner MY; Arbiser JL; Saxena NK; Sharma D
Oncotarget; 2015 Oct; 6(30):29947-62. PubMed ID: 26359358
[TBL] [Abstract][Full Text] [Related]
16. Honokiol abrogates leptin-induced tumor progression by inhibiting Wnt1-MTA1-β-catenin signaling axis in a microRNA-34a dependent manner.
Avtanski DB; Nagalingam A; Kuppusamy P; Bonner MY; Arbiser JL; Saxena NK; Sharma D
Oncotarget; 2015 Jun; 6(18):16396-410. PubMed ID: 26036628
[TBL] [Abstract][Full Text] [Related]
17. Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy.
Huang KJ; Kuo CH; Chen SH; Lin CY; Lee YR
J Cell Mol Med; 2018 Mar; 22(3):1894-1908. PubMed ID: 29363886
[TBL] [Abstract][Full Text] [Related]
18. Honokiol inhibits breast cancer cell metastasis by blocking EMT through modulation of Snail/Slug protein translation.
Wang WD; Shang Y; Li Y; Chen SZ
Acta Pharmacol Sin; 2019 Sep; 40(9):1219-1227. PubMed ID: 31235819
[TBL] [Abstract][Full Text] [Related]
19. Honokiol: a promising small molecular weight natural agent for the growth inhibition of oral squamous cell carcinoma cells.
Chen XR; Lu R; Dan HX; Liao G; Zhou M; Li XY; Ji N
Int J Oral Sci; 2011 Jan; 3(1):34-42. PubMed ID: 21449214
[TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis
Zou GL; Zuo S; Lu S; Hu RH; Lu YY; Yang J; Deng KS; Wu YT; Mu M; Zhu JJ; Zeng JZ; Zhang BF; Wu X; Zhao XK; Li HY
World J Gastroenterol; 2019 Aug; 25(30):4222-4234. PubMed ID: 31435175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
